C07K1/00	7	General methods for the preparation of peptides {, i.e. processes for the organic chemical preparation of peptides or proteins of any length}	C07K1/00	C07K1/00		654
C07K1/003	8	{by transforming the C-terminal amino acid to amides}	C07K1/00	C07K1/00		76
C07K1/006	8	{of peptides containing derivatised side chain amino acids}	C07K1/00	C07K1/00		391
C07K1/02	8	in solution {(C07K1/003, C07K1/006 take precedence)}	C07K1/02	C07K1/02		608
C07K1/023	9	{using racemisation inhibiting agents}	C07K1/02	C07K1/02		51
C07K1/026	9	{by fragment condensation in solution}	C07K1/02	C07K1/02		115
C07K1/04	8	on carriers {(C07K1/003, C07K1/006 take precedence)}	C07K1/04	C07K1/04		756
C07K1/042	9	{characterised by the nature of the carrier}	C07K1/04	C07K1/04		390
C07K1/045	9	{using devices to improve synthesis, e.g. reactors, special vessels}	C07K1/04	C07K1/04		318
C07K1/047	9	{Simultaneous synthesis of different peptide species; Peptide libraries}	C07K1/04	C07K1/04		746
C07K1/06	8	using protecting groups or activating agents {(C07K1/003, C07K1/006 take precedence)}	C07K1/06	C07K1/06		398
C07K1/061	9	{using protecting groups}	C07K1/06	C07K1/06		273
C07K1/062	10	{for alpha- or omega-carboxy functions}	C07K1/06	C07K1/06		107
C07K1/063	10	{for alpha-amino functions}	C07K1/06	C07K1/06		248
C07K1/064	10	{for omega-amino or -guanidino functions}	C07K1/06	C07K1/06		133
C07K1/065	10	{for hydroxy functions, not being part of carboxy functions}	C07K1/06	C07K1/06		42
C07K1/066	10	{for omega-amido functions}	C07K1/06	C07K1/06		28
C07K1/067	10	{for sulfur-containing functions}	C07K1/06	C07K1/06		91
C07K1/068	10	{for heterocyclic side chains}	C07K1/06	C07K1/06		28
C07K1/08	9	using activating agents {(C07K1/003, C07K1/006 take precedence)}	C07K1/08	C07K1/08		149
C07K1/082	10	{containing phosphorus}	C07K1/08	C07K1/08		41
C07K1/084	10	{containing nitrogen}	C07K1/08	C07K1/08		95
C07K1/086	10	{containing sulfur}	C07K1/08	C07K1/08		53
C07K1/088	10	{containing other elements, e.g. B, Si, As}	C07K1/08	C07K1/08		63
C07K1/10	8	using coupling agents {(C07K1/006 takes precedence)}	C07K1/10	C07K1/10		329
C07K1/107	8	by chemical modification of precursor peptides	C07K1/107	C07K1/107		509
C07K1/1072	9	{by covalent attachment of residues or functional groups}	C07K1/107	C07K1/107		137
C07K1/1075	10	{by covalent attachment of amino acids or peptide residues}	C07K1/107	C07K1/107		321
C07K1/1077	10	{by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids}	C07K1/107	C07K1/107		1253
C07K1/113	9	without change of the primary structure	C07K1/113	C07K1/113		294
C07K1/1133	10	{by redox-reactions involving cystein/cystin side chains}	C07K1/113	C07K1/113		292
C07K1/1136	10	{by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents}	C07K1/113	C07K1/113		323
C07K1/12	8	by hydrolysis {, i.e. solvolysis in general}	C07K1/12	C07K1/12		576
C07K1/122	9	{Hydrolysis with acids different from HF}	C07K1/12	C07K1/12		91
C07K1/124	9	{Hydrazinolysis}	C07K1/12	C07K1/12		11
C07K1/126	9	{Aminolysis}	C07K1/12	C07K1/12		25
C07K1/128	9	{sequencing}	C07K1/12	C07K1/12		92
C07K1/13	8	Labelling of peptides	C07K1/13	C07K1/13		691
C07K1/14	8	Extraction; Separation; Purification	C07K1/14	C07K1/14		2177
C07K1/145	9	{by extraction or solubilisation}	C07K1/14	C07K1/14		2305
C07K1/16	9	by chromatography	C07K1/16	C07K1/16		1386
C07K1/165	10	{mixed-mode chromatography}	C07K1/16	C07K1/16		230
C07K1/18	10	Ion-exchange chromatography	C07K1/18	C07K1/18		1476
C07K1/20	10	Partition-, reverse-phase or hydrophobic interaction chromatography	C07K1/20	C07K1/20		707
C07K1/22	10	Affinity chromatography or related techniques based upon selective absorption processes	C07K1/22	C07K1/22		2346
C07K1/24	9	by electrochemical means	C07K1/24	C07K1/24		104
C07K1/26	10	Electrophoresis	C07K1/26	C07K1/26		312
C07K1/28	11	Isoelectric focusing	C07K1/28	C07K1/28		83
C07K1/285	12	{multi dimensional electrophoresis}	C07K1/28	C07K1/28		36
C07K1/30	9	by precipitation	C07K1/30	C07K1/30		1293
C07K1/303	10	{by salting out}	C07K1/30	C07K1/30		178
C07K1/306	10	{by crystallization}<br><br><u>NOTE</u><br><br>Large single crystals of proteins from solutions are classified in C30B7/00 for the method and in C30B29/58 for the crystal.	C07K1/30	C07K1/30		227
C07K1/32	10	as complexes	C07K1/32	C07K1/32		138
C07K1/34	9	by filtration, ultrafiltration or reverse osmosis	C07K1/34	C07K1/34		3583
C07K1/36	9	by a combination of two or more processes of different types	C07K1/36	C07K1/36		2055
C07K2/00	7	Peptides of undefined number of amino acids; Derivatives thereof	C07K2/00	C07K2/00		435
C07K4/00	7	Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof	C07K4/00	C07K4/00		105
C07K4/02	8	from viruses	C07K4/02	C07K4/02		15
C07K4/04	8	from bacteria	C07K4/04	C07K4/04		45
C07K4/06	8	from fungi	C07K4/06	C07K4/06		13
C07K4/08	8	from algae; from lichens	C07K4/08	C07K4/08		3
C07K4/10	8	from plants	C07K4/10	C07K4/10		30
C07K4/12	8	from animals; from humans<br><br><u>NOTE</u><br><br>If no indication to the contrary is given, all amino acids are considered to be in the natural L-form	C07K4/12	C07K4/12		85
C07K5/00	7	Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof	C07K5/00	C07K5/00		180
C07K5/02	8	containing at least one abnormal peptide link	C07K5/02	C07K5/02		293
C07K5/0202	9	{containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids}	C07K5/02	C07K5/02		682
C07K5/0205	9	{containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof}	C07K5/02	C07K5/02		546
C07K5/0207	9	{containing the structure -NH-(X)4-C(=0), e.g. &apos;isosters&apos;, replacing two amino acids}	C07K5/02	C07K5/02		322
C07K5/021	9	{containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n &gt; 6, classification in C07K5/06&#160;-&#160;C07K5/10, according to the moiety having normal peptide bonds}	C07K5/02	C07K5/02		313
C07K5/0212	9	{containing the structure -N-C-N-C(=0)-, e.g. retro-inverso peptides}	C07K5/02	C07K5/02		50
C07K5/0215	9	{containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu}	C07K5/02	C07K5/02		666
C07K5/0217	9	{containing the structure -C(=O)-C-N-C(=O)-N-C-C(=O)-}	C07K5/02	C07K5/02		24
C07K5/022	9	{containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2}	C07K5/02	C07K5/02		73
C07K5/0222	10	{with the first amino acid being heterocyclic, e.g. Pro, Trp}	C07K5/02	C07K5/02		313
C07K5/0225	9	{containing the structure -N-C-C(=O)-N-C(=O)-C-N-}	C07K5/02	C07K5/02		
C07K5/0227	9	{containing the (partial) peptide sequence -Phe-His-NH-(X)2-C(=0)-, e.g. Renin-inhibitors with n = 2 - 6; for n &gt; 6 seeC07K5/06&#160;-&#160;C07K5/10}	C07K5/02	C07K5/02		215
C07K5/04	8	containing only normal peptide links<br><br><u>NOTE</u><br><br> In groups C07K5/06&#160;-&#160;C07K5/10 the following terms or expressions are used with the meaning indicated: <br>neutral:        amino acids having in the sidechain the same number of amino groups and carboxylic acid groups or derivatives thereof, e.g. Gly;<br>basic:          amino acids having in the sidechain more amino groups than carboxylic acid groups or derivatives thereof, e.g. Arg;<br>acidic:         amino acids having in the sidechain more carboxylic acid groups or derivatives thereof than amino groups, e.g. Asp;<br>aliphatic:      amino acids having only acyclic carbon atoms in the sidechain, e.g. Ala aromatic;<br>cycloaliphatic: amino acids having a carbocyclic ring in the sidechain, e.g. Phe<br>heterocyclic:   amino acids wherein the sidechain contains or is part of a heteroring, e.g. Pro;<br>side chain:     the R radical in the optionally functionalised amino acid R-CH(NH2)C02H)<br>	C07K5/04	C07K5/04		72
C07K5/06	9	Dipeptides	C07K5/06	C07K5/06		491
C07K5/06008	10	{with the first amino acid being neutral}	C07K5/06	C07K5/06		52
C07K5/06017	11	{and aliphatic}	C07K5/062	C07K5/06		172
C07K5/06026	12	{the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala}	C07K5/062	C07K5/06		1591
C07K5/06034	12	{the side chain containing 2 to 4 carbon atoms}	C07K5/062	C07K5/06		795
C07K5/06043	13	{Leu-amino acid}	C07K5/062	C07K5/06		485
C07K5/06052	13	{Val-amino acid}	C07K5/062	C07K5/06		578
C07K5/0606	12	{the side chain containing heteroatoms not provided for by C07K5/06086&#160;-&#160;C07K5/06139, e.g. Ser, Met, Cys, Thr}	C07K5/062	C07K5/06		525
C07K5/06069	13	{Ser-amino acid}	C07K5/062	C07K5/06		195
C07K5/06078	11	{and aromatic or cycloaliphatic}	C07K5/065	C07K5/06		1470
C07K5/06086	10	{with the first amino acid being basic}	C07K5/068	C07K5/06		563
C07K5/06095	11	{Arg-amino acid}	C07K5/072	C07K5/06		295
C07K5/06104	10	{with the first amino acid being acidic}	C07K5/072	C07K5/06		386
C07K5/06113	11	{Asp- or Asn-amino acid}	C07K5/072	C07K5/06		475
C07K5/06121	12	{the second amino acid being aromatic or cycloaliphatic}	C07K5/072	C07K5/06		44
C07K5/0613	13	{Aspartame}	C07K5/075	C07K5/06		330
C07K5/06139	10	{with the first amino acid being heterocyclic}	C07K5/078	C07K5/06		1131
C07K5/06147	11	{and His-amino acid; Derivatives thereof}	C07K5/078	C07K5/06		161
C07K5/06156	11	{and Trp-amino acid; Derivatives thereof}	C07K5/078	C07K5/06		221
C07K5/06165	11	{and Pro-amino acid; Derivatives thereof}	C07K5/078	C07K5/06		399
C07K5/06173	11	{and Glp-amino acid; Derivatives thereof}	C07K5/078	C07K5/06		85
C07K5/06182	11	{and Pristinamycin II; Derivatives thereof}	C07K5/078	C07K5/06		39
C07K5/06191	10	{containing heteroatoms different from O, S, or N}	C07K5/06	C07K5/06		877
C07K5/08	9	Tripeptides	C07K5/08	C07K5/08		354
C07K5/0802	10	{with the first amino acid being neutral}	C07K5/08	C07K5/08		66
C07K5/0804	11	{and aliphatic}	C07K5/083	C07K5/08		247
C07K5/0806	12	{the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala}	C07K5/083	C07K5/08		1062
C07K5/0808	12	{the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu}	C07K5/083	C07K5/08		961
C07K5/081	12	{the side chain containing O or S as heteroatoms, e.g. Cys, Ser}	C07K5/083	C07K5/08		486
C07K5/0812	11	{and aromatic or cycloaliphatic}	C07K5/087	C07K5/08		968
C07K5/0815	10	{with the first amino acid being basic}	C07K5/09	C07K5/08		476
C07K5/0817	11	{the first amino acid being Arg}	C07K5/09	C07K5/08		368
C07K5/0819	10	{with the first amino acid being acidic}	C07K5/093	C07K5/08		557
C07K5/0821	10	{with the first amino acid being heterocyclic, e.g. His, Pro, Trp}	C07K5/097	C07K5/08		731
C07K5/0823	11	{and Pro-amino acid; Derivatives thereof}	C07K5/097	C07K5/08		289
C07K5/0825	11	{and Glp-amino acid; Derivatives thereof}	C07K5/097	C07K5/08		85
C07K5/0827	10	{containing heteroatoms different from O, S, or N}	C07K5/08	C07K5/08		418
C07K5/10	9	Tetrapeptides	C07K5/10	C07K5/10		302
C07K5/1002	10	{with the first amino acid being neutral}	C07K5/10	C07K5/10		33
C07K5/1005	11	{and aliphatic}	C07K5/103	C07K5/10		212
C07K5/1008	12	{the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala}	C07K5/103	C07K5/10		880
C07K5/101	12	{the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu}	C07K5/103	C07K5/10		792
C07K5/1013	12	{the side chain containing O or S as heteroatoms, e.g. Cys, Ser}	C07K5/103	C07K5/10		550
C07K5/1016	11	{and aromatic or cycloaliphatic}	C07K5/107	C07K5/10		930
C07K5/1019	10	{with the first amino acid being basic}	C07K5/11	C07K5/10		807
C07K5/1021	10	{with the first amino acid being acidic}	C07K5/113	C07K5/10		599
C07K5/1024	10	{with the first amino acid being heterocyclic}	C07K5/117	C07K5/10		742
C07K5/1027	10	{containing heteroatoms different from O, S, or N}	C07K5/10	C07K5/10		152
C07K5/12	9	Cyclic peptides {with only normal peptide bonds in the ring}<br><br><u>NOTE</u><br><br>Cyclic peptides containing at least one abnormal peptide link are classified as linear peptides	C07K5/12	C07K5/12		189
C07K5/123	10	{Tripeptides}	C07K5/12	C07K5/12		61
C07K5/126	10	{Tetrapeptides}	C07K5/12	C07K5/12		137
C07K7/00	7	Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof<br><br><u>NOTE</u><br><br> In this subgroup cyclic compounds related to specific compounds which are classified in a specific group, e.g. C07K7/062, are classified in this specific group only 	C07K7/00	C07K7/00		354
C07K7/02	8	Linear peptides containing at least one abnormal peptide link	C07K7/02	C07K7/02		964
C07K7/04	8	Linear peptides containing only normal peptide links	C07K7/04	C07K7/04		144
C07K7/06	9	having 5 to 11 amino acids	C07K7/06	C07K7/06		11254
C07K7/062	10	{Serum thymic factor}	C07K7/06	C07K7/06		22
C07K7/065	10	{Thymic humoral factor}	C07K7/06	C07K7/06		6
C07K7/067	10	{Hemoregulatory peptides based on sequence Glp-Glu-Asp-Cys-Lys}	C07K7/06	C07K7/06		20
C07K7/08	9	having 12 to 20 amino acids (gastrins C07K14/595; somatostatins C07K14/655; melanotropins C07K14/68)	C07K7/08	C07K7/08		8452
C07K7/083	10	{Neurotensin}	C07K7/08	C07K7/08		68
C07K7/086	10	{Bombesin; Related peptides (having more than 20 amino acids C07K14/57572)}	C07K7/08	C07K7/08		83
C07K7/14	9	Angiotensins: Related peptides	C07K7/14	C07K7/14		214
C07K7/16	9	Oxytocins; Vasopressins; Related peptides	C07K7/16	C07K7/16		392
C07K7/18	9	Kallidins; Bradykinins; Related peptides	C07K7/18	C07K7/18		155
C07K7/22	9	{Tachykinins, e.g.} Eledoisins {, Substance P}; Related peptides	C07K7/22	C07K7/22		156
C07K7/23	9	Luteinising hormone-releasing hormone [LHRH]; Related peptides	C07K7/23	C07K7/23		650
C07K7/28	9	Gramicidins A, B, D; Related peptides	C07K7/28	C07K7/28		11
C07K7/50	8	Cyclic peptides containing at least one abnormal peptide link	C07K7/50	C07K7/50		131
C07K7/52	9	with only normal peptide links in the ring	C07K7/52	C07K7/52		74
C07K7/54	9	with at least one abnormal peptide link in the ring	C07K7/54	C07K7/54		203
C07K7/56	10	the cyclisation not occurring through 2,4-diamino-butanoic acid	C07K7/56	C07K7/56		975
C07K7/58	11	Bacitracins; Related peptides	C07K7/58	C07K7/58		79
C07K7/60	10	the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid	C07K7/60	C07K7/60		38
C07K7/62	11	Polymyxins; Related peptides	C07K7/62	C07K7/62		231
C07K7/64	8	Cyclic peptides containing only normal peptide links	C07K7/64	C07K7/64		1587
C07K7/645	9	{Cyclosporins; Related peptides}	C07K7/64	C07K7/64		297
C07K7/66	9	Gramicidins S, C; Tyrocidins A, B, C; Related peptides	C07K7/66	C07K7/66		42
C07K9/00	7	Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof	C07K9/00	C07K9/00		301
C07K9/001	8	{the peptide sequence having less than 12 amino acids and not being part of a ring structure}	C07K9/00	C07K9/00		207
C07K9/003	9	{Peptides being substituted by heterocyclic radicals, e.g. bleomycin, phleomycin}	C07K9/00	C07K9/00		109
C07K9/005	9	{containing within the molecule the substructure  with m, n &gt; 0 and m+n &gt; 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides}	C07K9/00	C07K9/00		193
C07K9/006	8	{the peptide sequence being part of a ring structure}	C07K9/00	C07K9/00		37
C07K9/008	9	{directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin}	C07K9/00	C07K9/00		423
C07K11/00	7	Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof	C07K11/00	C07K11/00		95
C07K11/02	8	cyclic, e.g. valinomycins {; Derivatives thereof}	C07K11/02	C07K11/02		246
C07K14/00	7	Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof	C07K14/00	C07K14/00		3973
C07K14/001	8	{by chemical synthesis}	C07K14/00	C07K14/00		2163
C07K14/003	9	{Peptide-nucleic acids (PNAs)}	C07K14/00	C07K14/00		350
C07K14/005	8	from viruses<br><br><u>NOTE</u><br><br> When classifying in this group, subject-matter related to viral proteins shall be classified by the symbol C07K14/005 together with (a number of) appropriate indexing codes out of C12N2710/00-C12N2795/00<br><br><u>WARNING</u><br> 1. From 2012-03-15 groups C07K14/01 - C07K14/19 and subgroups thereof are no longer used for the classification of new documents. 2. Reclassification of the back-file follows the principle outlined in the Note here above 	C07K14/005	C07K14/005		21149
C07K14/01	9	DNA viruses	C07K14/01	C07K14/01		112
C07K14/015	10	Parvoviridae, e.g. feline panleukopenia virus, human parvovirus	C07K14/015	C07K14/015		82
C07K14/02	10	Hepadnaviridae, e.g. hepatitis B virus	C07K14/02	C07K14/02		106
C07K14/025	10	Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus	C07K14/025	C07K14/025		124
C07K14/03	10	Herpetoviridae, e.g. pseudorabies virus	C07K14/03	C07K14/03		42
C07K14/032	11	{Pseudorabies virus, i.e. Anjetzky virus}	C07K14/03	C07K14/03		
C07K14/035	11	Herpes simplex virus I or II	C07K14/035	C07K14/035		37
C07K14/04	11	Varicella-zoster virus	C07K14/04	C07K14/04		20
C07K14/045	12	Cytomegalovirus	C07K14/045	C07K14/045		34
C07K14/05	11	Epstein-Barr virus	C07K14/05	C07K14/05		39
C07K14/055	11	Marek&apos;s disease virus	C07K14/055	C07K14/055		4
C07K14/06	11	Infectious bovine rhinotracheitis virus	C07K14/06	C07K14/06		1
C07K14/065	10	Poxviridae, e.g. avipoxvirus	C07K14/065	C07K14/065		18
C07K14/07	11	Vaccinia virus; Variola virus	C07K14/07	C07K14/07		20
C07K14/075	10	Adenoviridae	C07K14/075	C07K14/075		77
C07K14/08	9	RNA viruses	C07K14/08	C07K14/08		161
C07K14/082	10	{Arteriviridae, e.g. EAV, PRRSV}	C07K14/08	C07K14/08		9
C07K14/085	10	Picornaviridae, e.g. coxsackie virus, echovirus, enterovirus	C07K14/085	C07K14/085		26
C07K14/09	11	Foot-and-mouth disease virus	C07K14/09	C07K14/09		20
C07K14/095	11	Rhinovirus	C07K14/095	C07K14/095		9
C07K14/10	11	Hepatitis A virus	C07K14/10	C07K14/10		6
C07K14/105	11	Poliovirus	C07K14/105	C07K14/105		5
C07K14/11	10	Orthomyxoviridae, e.g. influenza virus	C07K14/11	C07K14/11		170
C07K14/115	10	Paramyxoviridae, e.g. parainfluenza virus	C07K14/115	C07K14/115		51
C07K14/12	11	Mumps virus; Measles virus	C07K14/12	C07K14/12		11
C07K14/125	11	Newcastle disease virus	C07K14/125	C07K14/125		5
C07K14/13	11	Canine distemper virus	C07K14/13	C07K14/13		1
C07K14/135	11	Respiratory syncytial virus	C07K14/135	C07K14/135		62
C07K14/14	10	Reoviridae, e.g. rotavirus, bluetongue virus, Colorado tick fever virus	C07K14/14	C07K14/14		26
C07K14/145	10	Rhabdoviridae, e.g. rabies virus, Duvenhage virus, Mokola virus or vesicular stomatitis virus	C07K14/145	C07K14/145		47
C07K14/15	10	Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus human T-cell leukaemia-lymphoma virus	C07K14/15	C07K14/15		44
C07K14/155	11	Lentiviridae, e.g. human immunodeficiency virus [HIV], visna-maedi virus or equine infectious anaemia virus	C07K14/155	C07K14/155		44
C07K14/16	12	HIV-1 {; HIV-2}	C07K14/16	C07K14/16		106
C07K14/161	13	{gag-pol, e.g. p55, p24/25, p17/18, p7, p6, p66/68, p51/52, p31/34, p32, p40}	C07K14/16	C07K14/16		31
C07K14/162	13	{env, e.g. gp160, gp110/120, gp41, V3, peptid T, CD4-Binding site}	C07K14/16	C07K14/16		89
C07K14/163	13	{Regulatory proteins, e.g. tat, nef, rev, vif, vpu, vpr, vpt, vpx}	C07K14/16	C07K14/16		26
C07K14/165	10	Coronaviridae, e.g. avian infectious bronchitis virus	C07K14/165	C07K14/165		346
C07K14/17	11	Porcine transmissible gastroenteritis virus	C07K14/17	C07K14/17		5
C07K14/175	10	Bunyaviridae, e.g. California encephalitis virus, Rift valley fever virus, Hantaan virus	C07K14/175	C07K14/175		7
C07K14/18	10	Togaviridae; {Flaviviridae}	C07K14/18	C07K14/18		66
C07K14/1808	11	{Alphaviruses or Group A arboviruses, e.g. sindbis, VEE, EEE, WEE, semliki forest virus (rubella virus C07K14/19)}	C07K14/18	C07K14/18		14
C07K14/1816	11	{Flaviviridae, e.g. pestivirus, mucosal disease virus, bovine viral diarrhoea virus, classical swine fever virus (hog cholera virus), border disease virus}	C07K14/18	C07K14/18		11
C07K14/1825	12	{Flaviviruses or Group B arboviruses, e.g. yellow fever virus, japanese encephalitis, tick-borne encephalitis, dengue}	C07K14/18	C07K14/18		51
C07K14/1833	12	{Hepatitis C; Hepatitis NANB}	C07K14/18	C07K14/18		33
C07K14/1841	12	{Hepatitis G; Hepatitis NANBNCNDNE}	C07K14/18	C07K14/18		2
C07K14/19	11	Rubella virus	C07K14/19	C07K14/19		7
C07K14/195	8	from bacteria<br><br><u>NOTE</u><br><br> In groups C07K14/20&#160;-&#160;C07K14/365, where appropriate, after the bacteria terminology, the indication of the order (O), family (F) or genus (G) of the bacteria is given in brackets. 	C07K14/195	C07K14/195		4348
C07K14/20	9	from Spirochaetales (O), e.g. Treponema, Leptospira	C07K14/20	C07K14/20		298
C07K14/205	9	from Campylobacter (G)	C07K14/205	C07K14/205		324
C07K14/21	9	from Pseudomonadaceae (F)	C07K14/21	C07K14/21		1029
C07K14/212	10	{Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter}	C07K14/21	C07K14/21		164
C07K14/215	9	from Halobacteriaceae (F)	C07K14/215	C07K14/215		71
C07K14/22	9	from Neisseriaceae (F)	C07K14/22	C07K14/22		468
C07K14/225	9	from Alcaligenes (G)	C07K14/225	C07K14/225		16
C07K14/23	9	from Brucella (G)	C07K14/23	C07K14/23		133
C07K14/235	9	from Bordetella (G)	C07K14/235	C07K14/235		254
C07K14/24	9	from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia	C07K14/24	C07K14/24		378
C07K14/245	10	Escherichia (G)	C07K14/245	C07K14/245		2753
C07K14/25	10	Shigella (G)	C07K14/25	C07K14/25		168
C07K14/255	10	Salmonella (G)	C07K14/255	C07K14/255		494
C07K14/26	10	Klebsiella (G)	C07K14/26	C07K14/26		170
C07K14/265	10	Enterobacter (G)	C07K14/265	C07K14/265		30
C07K14/27	10	Erwinia (G)	C07K14/27	C07K14/27		77
C07K14/275	10	Hafnia (G)	C07K14/275	C07K14/275		2
C07K14/28	9	from Vibrionaceae (F)	C07K14/28	C07K14/28		489
C07K14/285	9	from Pasteurellaceae (F), e.g. Haemophilus influenza	C07K14/285	C07K14/285		437
C07K14/29	9	from Richettsiales (O)	C07K14/29	C07K14/29		146
C07K14/295	9	from Chlamydiales (O)	C07K14/295	C07K14/295		238
C07K14/30	9	from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]	C07K14/30	C07K14/30		274
C07K14/305	9	from Micrococcaceae (F)	C07K14/305	C07K14/305		28
C07K14/31	10	from Staphylococcus (G)	C07K14/31	C07K14/31		1271
C07K14/315	9	from Streptococcus (G), e.g. Enterococci	C07K14/315	C07K14/315		1316
C07K14/3153	10	{Streptokinase}	C07K14/315	C07K14/315		141
C07K14/3156	10	{from Streptococcus pneumoniae (Pneumococcus) (Streptokinase C07K14/3153)}	C07K14/315	C07K14/315		403
C07K14/32	9	from Bacillus (G)	C07K14/32	C07K14/32		1397
C07K14/325	10	Bacillus thuringiensis crystal peptides, i.e. delta-endotoxins	C07K14/325	C07K14/325		1110
C07K14/33	9	from Clostridium (G)	C07K14/33	C07K14/33		1006
C07K14/335	9	from Lactobacillus (G)	C07K14/335	C07K14/335		362
C07K14/34	9	from Corynebacterium (G)	C07K14/34	C07K14/34		1072
C07K14/345	9	from Brevibacterium (G)	C07K14/345	C07K14/345		38
C07K14/35	9	from Mycobacteriaceae (F)	C07K14/35	C07K14/35		1075
C07K14/355	9	from Nocardia (G)	C07K14/355	C07K14/355		30
C07K14/36	9	from Actinomyces; from Streptomyces (G)	C07K14/36	C07K14/36		727
C07K14/365	9	from Actinoplanes (G)	C07K14/365	C07K14/365		27
C07K14/37	8	from fungi	C07K14/37	C07K14/37		1491
C07K14/375	9	from Basidiomycetes	C07K14/375	C07K14/375		240
C07K14/38	9	from Aspergillus	C07K14/38	C07K14/38		352
C07K14/385	9	from Penicillium	C07K14/385	C07K14/385		79
C07K14/39	9	from yeasts	C07K14/39	C07K14/39		794
C07K14/395	10	from Saccharomyces	C07K14/395	C07K14/395		1071
C07K14/40	10	from Candida	C07K14/40	C07K14/40		238
C07K14/405	8	from algae	C07K14/405	C07K14/405		550
C07K14/41	8	from lichens	C07K14/41	C07K14/41		7
C07K14/415	8	from plants	C07K14/415	C07K14/415		18972
C07K14/42	9	Lectins, e.g. concanavalin, phytohaemagglutinin	C07K14/42	C07K14/42		267
C07K14/425	9	Zeins	C07K14/425	C07K14/425		171
C07K14/43	9	{Sweetening agents, e.g.} thaumatin, {monellin}	C07K14/43	C07K14/43		147
C07K14/435	8	from animals; from humans	C07K14/435	C07K14/435		2417
C07K14/43504	9	{from invertebrates}	C07K14/435	C07K14/435		986
C07K14/43509	10	{from crustaceans}	C07K14/435	C07K14/435		390
C07K14/43513	10	{from arachnidae}	C07K14/435	C07K14/435		18
C07K14/43518	11	{from spiders}	C07K14/435	C07K14/435		544
C07K14/43522	11	{from scorpions}	C07K14/435	C07K14/435		179
C07K14/43527	11	{from ticks}	C07K14/435	C07K14/435		123
C07K14/43531	11	{from mites}	C07K14/435	C07K14/435		190
C07K14/43536	10	{from worms}	C07K14/435	C07K14/435		87
C07K14/4354	11	{from nematodes}	C07K14/435	C07K14/435		281
C07K14/43545	12	{from Caenorhabditis}	C07K14/435	C07K14/435		96
C07K14/4355	11	{from cestodes}	C07K14/435	C07K14/435		11
C07K14/43554	12	{from Taenia}	C07K14/435	C07K14/435		87
C07K14/43559	11	{from trematodes}	C07K14/435	C07K14/435		98
C07K14/43563	10	{from insects}	C07K14/435	C07K14/435		1112
C07K14/43568	11	{from wasps}	C07K14/435	C07K14/435		41
C07K14/43572	11	{from bees}	C07K14/435	C07K14/435		212
C07K14/43577	11	{from flies}	C07K14/435	C07K14/435		133
C07K14/43581	12	{from Drosophila}	C07K14/435	C07K14/435		313
C07K14/43586	11	{from silkworms}	C07K14/435	C07K14/435		796
C07K14/4359	11	{from fleas}	C07K14/435	C07K14/435		43
C07K14/43595	10	{from coelenteratae, e.g. medusae}	C07K14/435	C07K14/435		1312
C07K14/44	9	from protozoa	C07K14/44	C07K14/44		530
C07K14/445	10	Plasmodium	C07K14/445	C07K14/445		743
C07K14/45	10	Toxoplasma	C07K14/45	C07K14/45		157
C07K14/455	10	Eimeria	C07K14/455	C07K14/455		127
C07K14/46	9	from vertebrates	C07K14/46	C07K14/46		646
C07K14/461	10	{from fish}	C07K14/46	C07K14/46		954
C07K14/463	10	{from amphibians}	C07K14/46	C07K14/46		332
C07K14/465	10	from birds	C07K14/465	C07K14/465		423
C07K14/47	10	from mammals	C07K14/47	C07K14/47		16616
C07K14/4701	11	{not used}	C07K14/47	C07K14/47		22
C07K14/4702	12	{Regulators; Modulating activity}	C07K14/47	C07K14/47		4625
C07K14/4703	13	{Inhibitors; Suppressors}	C07K14/47	C07K14/47		2468
C07K14/4705	13	{stimulating, promoting or activating activity}	C07K14/47	C07K14/47		1482
C07K14/4706	14	{Guanosine triphosphatase activating protein, GAP}	C07K14/47	C07K14/47		60
C07K14/4707	12	{Muscular dystrophy}	C07K14/47	C07K14/47		134
C07K14/4708	13	{Duchenne dystrophy}	C07K14/47	C07K14/47		175
C07K14/471	13	{Myotonic dystrophy}	C07K14/47	C07K14/47		13
C07K14/4711	12	{Alzheimer&apos;s disease; Amyloid plaque core protein}	C07K14/47	C07K14/47		1393
C07K14/4712	12	{Cystic fibrosis}	C07K14/47	C07K14/47		209
C07K14/4713	12	{Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens}	C07K14/47	C07K14/47		729
C07K14/4715	12	{Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein}	C07K14/47	C07K14/47		229
C07K14/4716	12	{Muscle proteins, e.g. myosin, actin}	C07K14/47	C07K14/47		508
C07K14/4717	12	{Plasma globulins, lactoglobulin}	C07K14/47	C07K14/47		296
C07K14/4718	12	{Cytokine-induced proteins}	C07K14/47	C07K14/47		110
C07K14/472	12	{Complement proteins, e.g. anaphylatoxin, C3a, C5a}	C07K14/47	C07K14/47		373
C07K14/4721	12	{Lipocortins}	C07K14/47	C07K14/47		203
C07K14/4722	12	{G-proteins}	C07K14/47	C07K14/47		203
C07K14/4723	12	{Cationic antimicrobial peptides, e.g. defensins}	C07K14/47	C07K14/47		655
C07K14/4725	12	{Proteoglycans, e.g. aggreccan}	C07K14/47	C07K14/47		241
C07K14/4726	12	{Lectins}	C07K14/47	C07K14/47		279
C07K14/4727	12	{Mucins, e.g. human intestinal mucin}	C07K14/47	C07K14/47		262
C07K14/4728	12	{Calcium binding proteins, e.g. calmodulin}	C07K14/47	C07K14/47		275
C07K14/473	12	{alpha-Glycoproteins}	C07K14/47	C07K14/47		118
C07K14/4731	12	{Recognins, e.g. malignin}	C07K14/47	C07K14/47		22
C07K14/4732	12	{Casein (in foodstuffs A23J)}	C07K14/47	C07K14/47		625
C07K14/4733	12	{Acute pancreatitis-associated protein}	C07K14/47	C07K14/47		29
C07K14/4735	12	{Villin}	C07K14/47	C07K14/47		20
C07K14/4736	12	{Retinoblastoma protein}	C07K14/47	C07K14/47		67
C07K14/4737	12	{C-reactive protein}	C07K14/47	C07K14/47		57
C07K14/4738	12	{Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR (cell cycle dependent kinases C12N9/12)}	C07K14/47	C07K14/47		442
C07K14/474	12	{Pancreatic thread protein; Reg protein}	C07K14/47	C07K14/47		38
C07K14/4741	12	{Keratin; Cytokeratin}	C07K14/47	C07K14/47		311
C07K14/4742	12	{Bactericidal/Permeability-increasing protein [BPI]}	C07K14/47	C07K14/47		90
C07K14/4743	12	{Insulin-like growth factor binding protein}	C07K14/47	C07K14/47		139
C07K14/4745	12	{Cancer-associated SCM-recognition factor, CRISPP}	C07K14/47	C07K14/47		11
C07K14/4746	12	{p53}	C07K14/47	C07K14/47		519
C07K14/4747	12	{Apoptosis related proteins}	C07K14/47	C07K14/47		1249
C07K14/4748	12	{Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE}	C07K14/47	C07K14/47		2382
C07K14/475	9	Growth factors; Growth regulators	C07K14/475	C07K14/475		2568
C07K14/4753	10	{Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II}	C07K14/475	C07K14/475		238
C07K14/4756	10	{Neuregulins, i.e. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor}	C07K14/475	C07K14/475		206
C07K14/48	10	Nerve growth factor [NGF]	C07K14/48	C07K14/48		337
C07K14/485	10	Epidermal growth factor [EGF], i.e. urogastrone	C07K14/485	C07K14/485		731
C07K14/49	10	Platelet-derived growth factor [PDGF]	C07K14/49	C07K14/49		326
C07K14/495	10	Transforming growth factor [TGF]	C07K14/495	C07K14/495		849
C07K14/50	10	Fibroblast growth factor [FGF]	C07K14/50	C07K14/50		871
C07K14/501	11	{acidic FGF [aFGF]}	C07K14/50	C07K14/50		136
C07K14/503	11	{basic FGF [bFGF]}	C07K14/50	C07K14/50		343
C07K14/505	10	Erythropoietin [EPO]	C07K14/505	C07K14/505		752
C07K14/51	10	Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor	C07K14/51	C07K14/51		807
C07K14/515	10	Angiogenesic factors; Angiogenin	C07K14/515	C07K14/515		386
C07K14/52	9	Cytokines; Lymphokines; Interferons	C07K14/52	C07K14/52		2017
C07K14/521	10	{Chemokines}	C07K14/52	C07K14/52		485
C07K14/522	11	{Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC}	C07K14/52	C07K14/52		307
C07K14/523	11	{Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2}	C07K14/52	C07K14/52		434
C07K14/524	10	{Thrombopoietin, i.e. C-MPL ligand}	C07K14/52	C07K14/52		123
C07K14/525	10	Tumour necrosis factor [TNF]	C07K14/525	C07K14/525		946
C07K14/5255	11	{Lymphotoxin [LT]}	C07K14/525	C07K14/525		53
C07K14/53	10	Colony-stimulating factor [CSF]	C07K14/53	C07K14/53		220
C07K14/535	11	Granulocyte CSF; Granulocyte-macrophage CSF	C07K14/535	C07K14/535		1030
C07K14/54	10	Interleukins [IL]	C07K14/54	C07K14/54		1564
C07K14/5403	11	{IL-3}	C07K14/54	C07K14/54		156
C07K14/5406	11	{IL-4}	C07K14/54	C07K14/54		284
C07K14/5409	11	{IL-5}	C07K14/54	C07K14/54		91
C07K14/5412	11	{IL-6}	C07K14/54	C07K14/54		312
C07K14/5415	11	{Leukaemia inhibitory factor [LIF]}	C07K14/54	C07K14/54		40
C07K14/5418	11	{IL-7}	C07K14/54	C07K14/54		317
C07K14/5421	11	{IL-8}	C07K14/54	C07K14/54		121
C07K14/5425	11	{IL-9}	C07K14/54	C07K14/54		39
C07K14/5428	11	{IL-10}	C07K14/54	C07K14/54		426
C07K14/5431	11	{IL-11}	C07K14/54	C07K14/54		68
C07K14/5434	11	{IL-12}	C07K14/54	C07K14/54		711
C07K14/5437	11	{IL-13}	C07K14/54	C07K14/54		168
C07K14/544	11	{IL-14}	C07K14/54	C07K14/54		5
C07K14/5443	11	{IL-15}	C07K14/54	C07K14/54		946
C07K14/5446	11	{IL-16}	C07K14/54	C07K14/54		28
C07K14/545	11	IL-1	C07K14/545	C07K14/545		399
C07K14/55	11	IL-2	C07K14/55	C07K14/55		1611
C07K14/555	10	Interferons [IFN]	C07K14/555	C07K14/555		630
C07K14/56	11	IFN-alpha	C07K14/56	C07K14/56		921
C07K14/565	11	IFN-beta	C07K14/565	C07K14/565		462
C07K14/57	11	IFN-gamma	C07K14/57	C07K14/57		635
C07K14/575	9	Hormones (derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin C07K14/665, e.g. corticotropin C07K14/695)	C07K14/575	C07K14/575		1511
C07K14/57509	10	{Corticotropin releasing factor [CRF] (Urotensin)}	C07K14/575	C07K14/575		114
C07K14/57518	10	{Placental lactogen; Chorionic somatomammotropin}	C07K14/575	C07K14/575		18
C07K14/57527	10	{Calcitonin gene related peptide}	C07K14/575	C07K14/575		58
C07K14/57536	10	{Endothelin, vasoactive intestinal contractor [VIC]}	C07K14/575	C07K14/575		102
C07K14/57545	10	{Neuropeptide Y}	C07K14/575	C07K14/575		111
C07K14/57554	10	{Prolactin}	C07K14/575	C07K14/575		78
C07K14/57563	10	{Vasoactive intestinal peptide [VIP]; Related peptides}	C07K14/575	C07K14/575		406
C07K14/57572	10	{Gastrin releasing peptide (bombesin C07K7/086)}	C07K14/575	C07K14/575		50
C07K14/57581	10	{Thymosin; Related peptides}	C07K14/575	C07K14/575		218
C07K14/5759	10	{Products of obesity genes, e.g. leptin, obese (OB), tub, fat}	C07K14/575	C07K14/575		338
C07K14/58	10	Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin	C07K14/58	C07K14/58		347
C07K14/582	11	{at least 1 amino acid in D-form}	C07K14/58	C07K14/58		29
C07K14/585	10	Calcitonins	C07K14/585	C07K14/585		385
C07K14/5855	11	{at least 1 amino acid in D-form}	C07K14/585	C07K14/585		5
C07K14/59	10	Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]	C07K14/59	C07K14/59		664
C07K14/592	11	{at least 1 amino acid in D-form}	C07K14/59	C07K14/59		4
C07K14/595	10	Gastrins; Cholecystokinins [CCK]	C07K14/595	C07K14/595		151
C07K14/5955	11	{at least 1 amino acid in D-form}	C07K14/595	C07K14/595		18
C07K14/60	10	Growth hormone-releasing factor [GH-RF], i.e. somatoliberin	C07K14/60	C07K14/60		328
C07K14/605	10	Glucagons	C07K14/605	C07K14/605		1953
C07K14/61	10	Growth hormone [GH], i.e. somatotropin	C07K14/61	C07K14/61		1094
C07K14/615	11	Extraction from natural sources	C07K14/615	C07K14/615		16
C07K14/62	10	Insulins	C07K14/62	C07K14/62		1777
C07K14/622	11	{at least 1 amino acid in D-form}	C07K14/62	C07K14/62		13
C07K14/625	11	Extraction from natural sources	C07K14/625	C07K14/625		214
C07K14/63	10	Motilins	C07K14/63	C07K14/63		31
C07K14/635	10	Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides	C07K14/635	C07K14/635		393
C07K14/64	10	Relaxins	C07K14/64	C07K14/64		138
C07K14/645	10	Secretins	C07K14/645	C07K14/645		74
C07K14/65	10	Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2	C07K14/65	C07K14/65		570
C07K14/655	10	Somatostatins	C07K14/655	C07K14/655		298
C07K14/6555	11	{at least 1 amino acid in D-form}	C07K14/655	C07K14/655		296
C07K14/66	10	Thymopoietins	C07K14/66	C07K14/66		46
C07K14/662	11	{at least 1 amino acid in D-form}	C07K14/66	C07K14/66		18
C07K14/665	9	derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin	C07K14/665	C07K14/665		175
C07K14/67	10	Lipotropins, e.g. beta, gamma lipotropin	C07K14/67	C07K14/67		7
C07K14/672	11	{with at least 1 amino acid in D-form}	C07K14/67	C07K14/67		20
C07K14/675	10	Beta-endorphins	C07K14/675	C07K14/675		40
C07K14/6755	11	{with at least 1 amino acid in D-form}	C07K14/675	C07K14/675		33
C07K14/68	10	Melanocyte-stimulating hormone [MSH]	C07K14/68	C07K14/68		111
C07K14/685	11	Alpha-melanotropin	C07K14/685	C07K14/685		123
C07K14/69	11	Beta-melanotropin	C07K14/69	C07K14/69		14
C07K14/695	10	Corticotropin [ACTH]	C07K14/695	C07K14/695		267
C07K14/6955	11	{with at least 1 amino acid in D-form}	C07K14/695	C07K14/695		40
C07K14/70	10	Enkephalins	C07K14/70	C07K14/70		101
C07K14/702	11	{with at least 1 amino acid in D-form}	C07K14/70	C07K14/70		110
C07K14/705	9	Receptors; Cell surface antigens; Cell surface determinants {(tumour specific antigens C07K14/4748)}	C07K14/705	C07K14/705		10205
C07K14/70503	10	{Immunoglobulin superfamily}	C07K14/705	C07K14/705		2038
C07K14/70507	11	{CD2}	C07K14/705	C07K14/705		108
C07K14/7051	11	{T-cell receptor (TcR)-CD3 complex}	C07K14/725	C07K14/705		8000
C07K14/70514	11	{CD4}	C07K14/73	C07K14/705		565
C07K14/70517	11	{CD8}	C07K14/705	C07K14/705		1439
C07K14/70521	11	{CD28, CD152}	C07K14/705	C07K14/705		2065
C07K14/70525	11	{ICAM molecules, e.g. CD50, CD54, CD102}	C07K14/705	C07K14/705		191
C07K14/70528	11	{CD58}	C07K14/705	C07K14/705		79
C07K14/70532	11	{B7 molecules, e.g. CD80, CD86}	C07K14/705	C07K14/705		763
C07K14/70535	11	{Fc-receptors, e.g. CD16, CD32, CD64 (CD2314/705F)}	C07K14/735	C07K14/705		656
C07K14/70539	11	{MHC-molecules, e.g. HLA-molecules}	C07K14/74	C07K14/705		1907
C07K14/70542	11	{CD106}	C07K14/705	C07K14/705		55
C07K14/70546	10	{Integrin superfamily}	C07K14/705	C07K14/705		220
C07K14/7055	11	{Integrin beta1-subunit-containing molecules, e.g. CD29, CD49}	C07K14/705	C07K14/705		85
C07K14/70553	11	{Integrin beta2-subunit-containing molecules, e.g. CD11, CD18}	C07K14/705	C07K14/705		100
C07K14/70557	11	{Integrin beta3-subunit-containing molecules, e.g. CD41, CD51, CD61}	C07K14/705	C07K14/705		89
C07K14/7056	10	{Lectin superfamily, e.g. CD23, CD72}	C07K14/705	C07K14/705		470
C07K14/70564	11	{Selectins, e.g. CD62}	C07K14/705	C07K14/705		170
C07K14/70567	10	{Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors}	C07K14/705	C07K14/705		447
C07K14/70571	10	{for neuromediators, e.g. serotonin receptor, dopamine receptor}	C07K14/705	C07K14/705		1014
C07K14/70575	10	{NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154 (NGF C07K14/48, TNF C07K14/525)}	C07K14/705	C07K14/705		1102
C07K14/70578	10	{NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95 (NGF-receptor C07K14/71, TNF-receptor C07K14/7151)}	C07K14/705	C07K14/705		2265
C07K14/70582	10	{CD71}	C07K14/705	C07K14/705		62
C07K14/70585	10	{CD44}	C07K14/705	C07K14/705		94
C07K14/70589	10	{CD45}	C07K14/705	C07K14/705		57
C07K14/70592	10	{CD52}	C07K14/705	C07K14/705		25
C07K14/70596	10	{Molecules with a "CD"-designation not provided for elsewhere}	C07K14/705	C07K14/705		2199
C07K14/71	10	for growth factors; for growth regulators	C07K14/71	C07K14/71		2572
C07K14/715	10	for cytokines; for lymphokines; for interferons	C07K14/715	C07K14/715		773
C07K14/7151	11	{for tumor necrosis factor [TNF], for lymphotoxin [LT]}	C07K14/715	C07K14/715		553
C07K14/7153	11	{for colony-stimulating factors [CSF]}	C07K14/715	C07K14/715		109
C07K14/7155	11	{for interleukins [IL]}	C07K14/715	C07K14/715		1544
C07K14/7156	11	{for interferons [IFN]}	C07K14/715	C07K14/715		149
C07K14/7158	11	{for chemokines}	C07K14/715	C07K14/715		534
C07K14/72	10	for hormones {(for neuromediators C07K14/70571)}	C07K14/72	C07K14/72		794
C07K14/721	11	{Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor}	C07K14/72	C07K14/72		486
C07K14/723	11	{G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor}	C07K14/72	C07K14/72		1098
C07K14/745	9	Blood coagulation or fibrinolysis factors	C07K14/745	C07K14/745		735
C07K14/7455	10	{Thrombomodulin}	C07K14/745	C07K14/745		86
C07K14/75	10	Fibrinogen	C07K14/75	C07K14/75		586
C07K14/755	10	Factors VIII {, e.g. factor VIII C (AHF), factor VIII Ag (VWF)}	C07K14/755	C07K14/755		1151
C07K14/76	9	Albumins	C07K14/76	C07K14/76		569
C07K14/765	10	Serum albumin, e.g. HSA	C07K14/765	C07K14/765		2174
C07K14/77	10	Ovalbumin	C07K14/77	C07K14/77		905
C07K14/775	9	Apolipopeptides	C07K14/775	C07K14/775		908
C07K14/78	9	Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]	C07K14/78	C07K14/78		5478
C07K14/785	9	Alveolar surfactant peptides; Pulmonary surfactant peptides	C07K14/785	C07K14/785		151
C07K14/79	9	Transferrins, e.g. lactoferrins, ovotransferrins	C07K14/79	C07K14/79		885
C07K14/795	8	Porphyrin- or corrin-ring-containing peptides	C07K14/795	C07K14/795		848
C07K14/80	9	Cytochromes	C07K14/80	C07K14/80		199
C07K14/805	9	Haemoglobins; Myoglobins	C07K14/805	C07K14/805		1007
C07K14/81	8	Protease inhibitors	C07K14/81	C07K14/81		300
C07K14/8103	9	{Exopeptidase (E.C. 3.4.11-19) inhibitors}	C07K14/81	C07K14/81		63
C07K14/8107	9	{Endopeptidase (E.C. 3.4.21-99) inhibitors}	C07K14/81	C07K14/81		94
C07K14/811	10	{Serine protease (E.C. 3.4.21) inhibitors}	C07K14/81	C07K14/81		583
C07K14/8114	11	{Kunitz type inhibitors}	C07K14/81	C07K14/81		282
C07K14/8117	12	{Bovine/basic pancreatic trypsin inhibitor (BPTI, aprotinin)}	C07K14/81	C07K14/81		119
C07K14/8121	11	{Serpins}	C07K14/81	C07K14/81		330
C07K14/8125	12	{Alpha-1-antitrypsin}	C07K14/81	C07K14/81		343
C07K14/8128	12	{Antithrombin III}	C07K14/81	C07K14/81		107
C07K14/8132	12	{Plasminogen activator inhibitors}	C07K14/81	C07K14/81		97
C07K14/8135	11	{Kazal type inhibitors, e.g. pancreatic secretory inhibitor, ovomucoid}	C07K14/81	C07K14/81		93
C07K14/8139	10	{Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin}	C07K14/81	C07K14/81		282
C07K14/8142	10	{Aspartate protease (E.C. 3.4.23) inhibitors, e.g. HIV protease inhibitors}	C07K14/81	C07K14/81		28
C07K14/8146	10	{Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP}	C07K14/81	C07K14/81		169
C07K14/815	9	from leeches, e.g. hirudin, eglin	C07K14/815	C07K14/815		403
C07K14/82	8	Translation products from oncogenes	C07K14/82	C07K14/82		1652
C07K14/825	8	Metallothioneins	C07K14/825	C07K14/825		163
C07K16/00	7	Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies<br><br><u>NOTE</u><br><br> In this main group, where appropriate, after the virus or bacteria terminology, the indication of the order (O), family (F) or genus (G) is given in parentheses.<br>Documents characterised by the technical aspects of the construction of an antibody or fragment thereof, should be classified in groups C07K16/00 - C07K16/065 or groups C07K16/46 - C07K16/468.<br>Documents not characterised by the technical aspects of the construction of an antibody or fragment thereof, should be classified only according to their specificity, where necessary accompanied by one or more appropriate indexing codes.	C07K16/00	C07K16/00		7486
C07K16/005	8	{constructed by phage libraries}	C07K16/00	C07K16/00		933
C07K16/02	8	from eggs	C07K16/02	C07K16/02		631
C07K16/04	8	from milk	C07K16/04	C07K16/04		168
C07K16/06	8	from serum	C07K16/06	C07K16/06		879
C07K16/065	9	{Purification, fragmentation}	C07K16/06	C07K16/06		1595
C07K16/08	8	against material from viruses	C07K16/08	C07K16/08		365
C07K16/081	9	DNA viruses	C07K16/081	C07K16/081		761
C07K16/082	10	Hepadnaviridae (F), e.g. hepatitis B virus	C07K16/082	C07K16/082		391
C07K16/084	10	Papillomaviridae (F); Polyomaviridae (F), e.g. SV40, BK virus or JC virus	C07K16/084	C07K16/084		254
C07K16/085	10	Orthoherpesviridae (F), e.g. pseudorabies virus or Epstein-Barr virus	C07K16/085	C07K16/085		251
C07K16/087	11	Herpes simplex virus	C07K16/087	C07K16/087		125
C07K16/088	11	{Varicella-zoster virus}	C07K16/085	C07K16/08		80
C07K16/089	11	{Cytomegalovirus}	C07K16/085	C07K16/08		127
C07K16/10	9	RNA viruses	C07K16/10	C07K16/10		2191
C07K16/102	10	Coronaviridae (F)	C07K16/102	C07K16/102		
C07K16/104	11	Severe acute respiratory syndrome coronavirus 2 [SARS‐CoV‐2]	C07K16/104	C07K16/104		
C07K16/106	10	Picornaviridae (F), e.g. hepatitis A virus	C07K16/106	C07K16/106		
C07K16/108	10	Orthomyxoviridae (F), e.g. influenza virus	C07K16/108	C07K16/108		
C07K16/11	10	Paramyxoviridae (F); Pneumoviridae (F), e.g. respiratory syncytial virus [RSV]	C07K16/11	C07K16/11		
C07K16/112	10	Retroviridae (F), e.g. leukemia viruses	C07K16/112	C07K16/112		
C07K16/114	11	Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]	C07K16/114	C07K16/114		
C07K16/1143	12	{Gag-pol proteins, e.g. p17or p24}	C07K16/114	C07K16/114		
C07K16/1145	12	{Env proteins, e.g. gp41, gp110/120, gp160, V3, principal neutralising domain [PND] or CD4-binding site}	C07K16/114	C07K16/114		
C07K16/1147	12	{Regulatory proteins, e.g. trans-activator of transcription [TAT], rev or vacuolar protein targeting [VPT]}	C07K16/114	C07K16/114		
C07K16/116	10	Togaviridae (F); Matonaviridae (F); Flaviviridae (F)	C07K16/116	C07K16/116		
C07K16/118	11	Hepatitis C virus; GB virus C [GBV-C]	C07K16/118	C07K16/118		
C07K16/12	8	against material from bacteria	C07K16/12	C07K16/12		517
C07K16/1203	9	Gram-negative bacteria	C07K16/1203	C07K16/1203		336
C07K16/1207	10	{from Spirochaetales (O), e.g. Treponema, Leptospira}	C07K16/1203	C07K16/12		97
C07K16/121	10	Helicobacter (G); Campylobacter (G)	C07K16/121	C07K16/121		184
C07K16/1214	10	Pseudomonadaceae (F)	C07K16/1214	C07K16/1214		250
C07K16/1217	10	Neisseriaceae (F)	C07K16/1217	C07K16/1217		150
C07K16/1218	10	Acinetobacter (G)	C07K16/1218	C07K16/1218		24
C07K16/1221	10	{from Brucella (G)}	C07K16/1203	C07K16/12		32
C07K16/1225	10	{from Bordetella (G)}	C07K16/1203	C07K16/12		36
C07K16/1228	10	Enterobacterales (O), e.g. Citrobacter (G), Serratia (G), Proteus (G), Providencia (G), Morganella (G) or Yersinia (G)	C07K16/1228	C07K16/1228		156
C07K16/1232	11	Escherichia (G)	C07K16/1232	C07K16/1232		336
C07K16/1235	11	Salmonella (G)	C07K16/1235	C07K16/1235		116
C07K16/1239	10	{from Vibrionaceae (G)}	C07K16/1203	C07K16/12		84
C07K16/1242	10	{from Pasteurellaceae (F), e.g. Haemophilus influenza}	C07K16/1203	C07K16/12		117
C07K16/1246	10	Rickettsiales (O)	C07K16/1246	C07K16/1246		43
C07K16/125	10	{from Chlamydiales (O)}	C07K16/1203	C07K16/12		55
C07K16/1253	10	{from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]}	C07K16/1203	C07K16/12		103
C07K16/1257	10	{from Bacteridaceae (F)}	C07K16/1203	C07K16/12		19
C07K16/126	10	Legionella (G)	C07K16/126	C07K16/126		16
C07K16/1264	10	{from Rhizobiaceae (F)}	C07K16/1203	C07K16/126		4
C07K16/1267	9	Gram-positive bacteria	C07K16/1267	C07K16/1267		104
C07K16/1271	10	Micrococcaceae (F); Staphylococcaceae (F), e.g. Staphylococcus (G)	C07K16/1271	C07K16/1271		499
C07K16/1275	10	Streptococcus (G)	C07K16/1275	C07K16/1275		365
C07K16/1278	10	Bacillus (G)	C07K16/1278	C07K16/1278		194
C07K16/1282	10	Clostridium (G)	C07K16/1282	C07K16/1282		462
C07K16/1285	10	{from Corynebacterium (G)}	C07K16/1267	C07K16/12		38
C07K16/1289	10	Mycobacteriaceae (F)	C07K16/1289	C07K16/1289		194
C07K16/1292	10	{from Actinomyces; from Streptomyces (G)}	C07K16/1267	C07K16/12		42
C07K16/1296	10	{from Listeria}	C07K16/1267	C07K16/12		37
C07K16/14	8	against material from fungi, algea or lichens	C07K16/14	C07K16/14		526
C07K16/16	8	against material from plants	C07K16/16	C07K16/16		454
C07K16/18	8	against material from animals or humans	C07K16/18	C07K16/18		11895
C07K16/20	9	from protozoa	C07K16/20	C07K16/20		318
C07K16/205	10	{Plasmodium}	C07K16/20	C07K16/20		232
C07K16/22	9	against growth factors {; against growth regulators}	C07K16/22	C07K16/22		3747
C07K16/24	9	against cytokines, lymphokines or interferons	C07K16/24	C07K16/24		1473
C07K16/241	10	{Tumor Necrosis Factors}	C07K16/24	C07K16/24		1667
C07K16/242	11	{Lymphotoxin [LT]}	C07K16/24	C07K16/24		26
C07K16/243	10	{Colony Stimulating Factors}	C07K16/24	C07K16/24		238
C07K16/244	10	{Interleukins [IL]}	C07K16/24	C07K16/24		2048
C07K16/245	11	{IL-1}	C07K16/24	C07K16/24		309
C07K16/246	11	{IL-2}	C07K16/24	C07K16/24		167
C07K16/247	11	{IL-4}	C07K16/24	C07K16/24		163
C07K16/248	11	{IL-6}	C07K16/24	C07K16/24		488
C07K16/249	10	{Interferons}	C07K16/24	C07K16/24		345
C07K16/26	9	against hormones {; against hormone releasing or inhibiting factors}	C07K16/26	C07K16/26		1443
C07K16/28	9	against receptors, cell surface antigens or cell surface determinants	C07K16/28	C07K16/28		7683
C07K16/2803	10	{against the immunoglobulin superfamily}	C07K16/28	C07K16/28		7033
C07K16/2806	11	{against CD2}	C07K16/28	C07K16/28		193
C07K16/2809	11	{against the T-cell receptor (TcR)-CD3 complex}	C07K16/28	C07K16/28		3652
C07K16/2812	11	{against CD4}	C07K16/28	C07K16/28		513
C07K16/2815	11	{against CD8}	C07K16/28	C07K16/28		372
C07K16/2818	11	{against CD28 or CD152}	C07K16/28	C07K16/28		5608
C07K16/2821	11	{against ICAM molecules, e.g. CD50, CD54, CD102}	C07K16/28	C07K16/28		282
C07K16/2824	11	{against CD58}	C07K16/28	C07K16/28		31
C07K16/2827	11	{against B7 molecules, e.g. CD80, CD86}	C07K16/28	C07K16/28		3730
C07K16/283	11	{against Fc-receptors, e.g. CD16, CD32, CD64 (CD23 C07K16/2851)}	C07K16/28	C07K16/28		1039
C07K16/2833	11	{against MHC-molecules, e.g. HLA-molecules}	C07K16/28	C07K16/28		1081
C07K16/2836	11	{against CD106}	C07K16/28	C07K16/28		75
C07K16/2839	10	{against the integrin superfamily}	C07K16/28	C07K16/28		463
C07K16/2842	11	{against integrin beta1-subunit-containing molecules, e.g. CD29, CD49}	C07K16/28	C07K16/28		329
C07K16/2845	11	{against integrin beta2-subunit-containing molecules, e.g. CD11, CD18}	C07K16/28	C07K16/28		270
C07K16/2848	11	{against integrin beta3-subunit-containing molecules, e.g. CD41, CD51, CD61}	C07K16/28	C07K16/28		232
C07K16/2851	10	{against the lectin superfamily, e.g. CD23, CD72}	C07K16/28	C07K16/28		1037
C07K16/2854	11	{against selectins, e.g. CD62}	C07K16/28	C07K16/28		189
C07K16/2857	10	{against nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, orphan receptor}	C07K16/28	C07K16/28		54
C07K16/286	10	{against neuromediator receptors, e.g. serotonin receptor, dopamine receptor}	C07K16/28	C07K16/28		221
C07K16/2863	10	{against receptors for growth factors, growth regulators}	C07K16/28	C07K16/28		4412
C07K16/2866	10	{against receptors for cytokines, lymphokines, interferons}	C07K16/28	C07K16/28		3391
C07K16/2869	10	{against hormone receptors (for antibodies against neuromediator receptors C07K16/286)}	C07K16/28	C07K16/28		633
C07K16/2872	10	{against prion molecules, e.g. CD230}	C07K16/28	C07K16/28		66
C07K16/2875	10	{against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154 (against NGF C07K16/22, against TNF C07K16/241)}	C07K16/28	C07K16/28		1139
C07K16/2878	10	{against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95}	C07K16/28	C07K16/28		3361
C07K16/2881	10	{against CD71}	C07K16/28	C07K16/28		402
C07K16/2884	10	{against CD44}	C07K16/28	C07K16/28		190
C07K16/2887	10	{against CD20}	C07K16/28	C07K16/28		2060
C07K16/289	10	{against CD45}	C07K16/28	C07K16/28		213
C07K16/2893	10	{against CD52}	C07K16/28	C07K16/28		172
C07K16/2896	10	{against molecules with a "CD"-designation, not provided for elsewhere}	C07K16/28	C07K16/28		3813
C07K16/30	10	from tumour cells	C07K16/30	C07K16/30		5811
C07K16/3007	11	{Carcino-embryonic Antigens}	C07K16/30	C07K16/30		701
C07K16/3015	11	{Breast}	C07K16/30	C07K16/30		659
C07K16/3023	11	{Lung}	C07K16/30	C07K16/30		427
C07K16/303	11	{Liver or Pancreas}	C07K16/30	C07K16/30		786
C07K16/3038	11	{Kidney, bladder}	C07K16/30	C07K16/30		206
C07K16/3046	11	{Stomach, Intestines}	C07K16/30	C07K16/30		551
C07K16/3053	11	{Skin, nerves, brain}	C07K16/30	C07K16/30		497
C07K16/3061	11	{Blood cells}	C07K16/30	C07K16/30		570
C07K16/3069	11	{Reproductive system, e.g. ovaria, uterus, testes, prostate}	C07K16/30	C07K16/30		1211
C07K16/3076	11	{against structure-related tumour-associated moieties}	C07K16/30	C07K16/30		173
C07K16/3084	12	{against tumour-associated gangliosides}	C07K16/30	C07K16/30		290
C07K16/3092	12	{against tumour-associated mucins}	C07K16/30	C07K16/30		559
C07K16/32	9	against translation products of oncogenes	C07K16/32	C07K16/32		4017
C07K16/34	9	against blood group antigens	C07K16/34	C07K16/34		244
C07K16/36	9	against blood coagulation factors	C07K16/36	C07K16/36		715
C07K16/38	8	against protease inhibitors of peptide structure	C07K16/38	C07K16/38		325
C07K16/40	8	against enzymes	C07K16/40	C07K16/40		5974
C07K16/42	8	against immunoglobulins	C07K16/42	C07K16/42		408
C07K16/4208	9	{against an idiotypic determinant on Ig}	C07K16/42	C07K16/42		188
C07K16/4216	10	{against anti-viral Ig}	C07K16/42	C07K16/42		42
C07K16/4225	11	{against anti-HIV Ig}	C07K16/42	C07K16/42		32
C07K16/4233	10	{against anti-bacterial Ig}	C07K16/42	C07K16/42		29
C07K16/4241	10	{against anti-human or anti-animal Ig}	C07K16/42	C07K16/42		259
C07K16/425	11	{against anti-protozoal Ig}	C07K16/42	C07K16/42		9
C07K16/4258	11	{against anti-receptor Ig}	C07K16/42	C07K16/42		105
C07K16/4266	12	{against anti-tumor receptor Ig}	C07K16/42	C07K16/42		152
C07K16/4275	12	{against anti-CD4 Ig}	C07K16/42	C07K16/42		10
C07K16/4283	9	{against an allotypic or isotypic determinant on Ig}	C07K16/42	C07K16/42		347
C07K16/4291	10	{against IgE}	C07K16/42	C07K16/42		393
C07K16/44	8	against material not provided for elsewhere {, e.g. haptens, metals, DNA, RNA, amino acids}	C07K16/44	C07K16/44		3572
C07K16/46	8	Hybrid immunoglobulins (hybrids of an immunoglobulin with a peptide not being an immunoglobulin C07K19/00)	C07K16/46	C07K16/46		1212
C07K16/461	9	{Igs containing Ig-regions, -domains or -residues form different species}	C07K16/46	C07K16/46		150
C07K16/462	10	{Igs containing a variable region (Fv) from one specie and a constant region (Fc) from another}	C07K16/46	C07K16/46		217
C07K16/464	10	{Igs containing CDR-residues from one specie grafted between FR-residues from another}	C07K16/46	C07K16/46		125
C07K16/465	11	{with additional modified FR-residues}	C07K16/46	C07K16/46		86
C07K16/467	10	{Igs with modifications in the FR-residues only}	C07K16/46	C07K16/46		37
C07K16/468	9	{Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies}	C07K16/46	C07K16/46		1651
C07K17/00	7	Carrier-bound or immobilised peptides (carrier-bound or immobilised enzymes C12N11/00); Preparation thereof	C07K17/00	C07K17/00		380
C07K17/02	8	Peptides being immobilised on, or in, an organic carrier	C07K17/02	C07K17/02		285
C07K17/04	9	entrapped within the carrier, e.g. gel, hollow fibre	C07K17/04	C07K17/04		89
C07K17/06	9	attached to the carrier via a bridging agent	C07K17/06	C07K17/06		277
C07K17/08	9	the carrier being a synthetic polymer	C07K17/08	C07K17/08		425
C07K17/10	9	the carrier being a carbohydrate	C07K17/10	C07K17/10		174
C07K17/12	10	Cellulose or derivatives thereof	C07K17/12	C07K17/12		65
C07K17/14	8	Peptides being immobilised on, or in, an inorganic carrier	C07K17/14	C07K17/14		470
C07K19/00	7	Hybrid peptides {, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes}	C07K19/00	C07K19/00		4460
C07K2299/00	7	Coordinates from 3D structures of peptides, e.g. proteins or enzymes	CPCONLY	C07K2299/00		1157
C07K2317/00	7	Immunoglobulins specific features	CPCONLY	C07K2317/00		106
C07K2317/10	8	characterized by their source of isolation or production	CPCONLY	C07K2317/10		510
C07K2317/11	9	isolated from eggs	CPCONLY	C07K2317/11		518
C07K2317/12	9	isolated from milk	CPCONLY	C07K2317/12		105
C07K2317/13	9	isolated from plants	CPCONLY	C07K2317/13		132
C07K2317/14	9	Specific host cells or culture conditions, e.g. components, pH or temperature	CPCONLY	C07K2317/14		1863
C07K2317/20	8	characterized by taxonomic origin	CPCONLY	C07K2317/20		598
C07K2317/21	9	from primates, e.g. man	CPCONLY	C07K2317/21		6978
C07K2317/22	9	from camelids, e.g. camel, llama or dromedary	CPCONLY	C07K2317/22		1860
C07K2317/23	9	from birds	CPCONLY	C07K2317/23		361
C07K2317/24	9	containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered	CPCONLY	C07K2317/24		13962
C07K2317/30	8	characterized by aspects of specificity or valency	CPCONLY	C07K2317/30		694
C07K2317/31	9	multispecific	CPCONLY	C07K2317/31		7784
C07K2317/32	9	specific for a neo-epitope on a complex, e.g. antibody-antigen or ligand-receptor	CPCONLY	C07K2317/32		626
C07K2317/33	9	Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity	CPCONLY	C07K2317/33		6145
C07K2317/34	9	Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues	CPCONLY	C07K2317/34		6365
C07K2317/35	9	Valency	CPCONLY	C07K2317/35		1689
C07K2317/40	8	characterized by post-translational modification	CPCONLY	C07K2317/40		373
C07K2317/41	9	Glycosylation, sialylation, or fucosylation	CPCONLY	C07K2317/41		1818
C07K2317/50	8	characterized by immunoglobulin fragments	CPCONLY	C07K2317/50		207
C07K2317/51	9	Complete heavy chain or Fd fragment, i.e. VH + CH1	CPCONLY	C07K2317/51		1848
C07K2317/515	9	Complete light chain, i.e. VL + CL	CPCONLY	C07K2317/515		1920
C07K2317/52	9	Constant or Fc region; Isotype	CPCONLY	C07K2317/52		5599
C07K2317/522	10	CH1 domain	CPCONLY	C07K2317/522		690
C07K2317/524	10	CH2 domain	CPCONLY	C07K2317/524		1375
C07K2317/526	10	CH3 domain	CPCONLY	C07K2317/526		1539
C07K2317/528	10	CH4 domain	CPCONLY	C07K2317/528		75
C07K2317/53	10	Hinge	CPCONLY	C07K2317/53		1316
C07K2317/54	9	F(ab&apos;)2	CPCONLY	C07K2317/54		1054
C07K2317/55	9	Fab or Fab&apos;	CPCONLY	C07K2317/55		5194
C07K2317/56	9	variable (Fv) region, i.e. VH and/or VL	CPCONLY	C07K2317/56		9886
C07K2317/565	10	Complementarity determining region [CDR]	CPCONLY	C07K2317/565		14943
C07K2317/567	10	Framework region [FR]	CPCONLY	C07K2317/567		2807
C07K2317/569	10	Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody&#174;	CPCONLY	C07K2317/569		4649
C07K2317/60	8	characterized by non-natural combinations of immunoglobulin fragments	CPCONLY	C07K2317/60		379
C07K2317/62	9	comprising only variable region components	CPCONLY	C07K2317/62		219
C07K2317/622	10	Single chain antibody (scFv)	CPCONLY	C07K2317/622		10614
C07K2317/624	10	Disulfide-stabilized antibody (dsFv)	CPCONLY	C07K2317/624		265
C07K2317/626	10	Diabody or triabody	CPCONLY	C07K2317/626		523
C07K2317/64	9	comprising a combination of variable region and constant region components	CPCONLY	C07K2317/64		1306
C07K2317/66	9	comprising a swap of domains, e.g. CH3-CH2, VH-CL or VL-CH1	CPCONLY	C07K2317/66		204
C07K2317/70	8	characterized by effect upon binding to a cell or to an antigen	CPCONLY	C07K2317/70		1137
C07K2317/71	9	Decreased effector function due to an Fc-modification	CPCONLY	C07K2317/71		1403
C07K2317/72	9	Increased effector function due to an Fc-modification	CPCONLY	C07K2317/72		892
C07K2317/73	9	Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation	CPCONLY	C07K2317/73		7418
C07K2317/732	10	Antibody-dependent cellular cytotoxicity [ADCC]	CPCONLY	C07K2317/732		3579
C07K2317/734	10	Complement-dependent cytotoxicity [CDC]	CPCONLY	C07K2317/734		1403
C07K2317/74	9	Inducing cell proliferation	CPCONLY	C07K2317/74		851
C07K2317/75	9	Agonist effect on antigen	CPCONLY	C07K2317/75		2070
C07K2317/76	9	Antagonist effect on antigen, e.g. neutralization or inhibition of binding	CPCONLY	C07K2317/76		16944
C07K2317/77	9	Internalization into the cell	CPCONLY	C07K2317/77		2497
C07K2317/80	8	remaining in the (producing) cell, i.e. intracellular antibodies or intrabodies	CPCONLY	C07K2317/80		85
C07K2317/81	9	functional in the endoplasmatic reticulum [ER] or the Golgi apparatus	CPCONLY	C07K2317/81		14
C07K2317/82	9	functional in the cytoplasm, the inner aspect of the cell membrane, the nucleus or the mitochondria	CPCONLY	C07K2317/82		62
C07K2317/90	8	characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin	CPCONLY	C07K2317/90		1025
C07K2317/92	9	Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value	CPCONLY	C07K2317/92		16023
C07K2317/94	9	Stability, e.g. half-life, pH, temperature or enzyme-resistance	CPCONLY	C07K2317/94		4736
C07K2318/00	7	Antibody mimetics or scaffolds	CPCONLY	C07K2318/00		128
C07K2318/10	8	Immunoglobulin or domain(s) thereof as scaffolds for inserted non-Ig peptide sequences, e.g. for vaccination purposes	CPCONLY	C07K2318/10		154
C07K2318/20	8	Antigen-binding scaffold molecules wherein the scaffold is not an immunoglobulin variable region or antibody mimetics	CPCONLY	C07K2318/20		436
C07K2319/00	7	Fusion polypeptide	CPCONLY	C07K2319/00		23470
C07K2319/01	8	containing a localisation/targetting motif	CPCONLY	C07K2319/01		1070
C07K2319/02	9	containing a signal sequence	CPCONLY	C07K2319/02		7814
C07K2319/03	9	containing a transmembrane segment	CPCONLY	C07K2319/03		6880
C07K2319/033	9	containing a motif for targeting to the internal surface of the plasma membrane, e.g. containing a myristoylation motif	CPCONLY	C07K2319/033		197
C07K2319/034	9	containing a motif for targeting to the periplasmic space of Gram negative bacteria as a soluble protein, i.e. signal sequence should be cleaved	CPCONLY	C07K2319/034		139
C07K2319/035	9	containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins	CPCONLY	C07K2319/035		609
C07K2319/036	9	targeting to the medium outside of the cell, e.g. type III secretion	CPCONLY	C07K2319/036		501
C07K2319/04	9	containing an ER retention signal such as a C-terminal HDEL motif	CPCONLY	C07K2319/04		260
C07K2319/05	9	containing a GOLGI retention signal	CPCONLY	C07K2319/05		46
C07K2319/055	9	containing a signal for localisation to secretory granules (for exocytosis)	CPCONLY	C07K2319/055		51
C07K2319/06	9	containing a lysosomal/endosomal localisation signal	CPCONLY	C07K2319/06		179
C07K2319/07	9	containing a mitochondrial localisation signal	CPCONLY	C07K2319/07		187
C07K2319/08	9	containing a chloroplast localisation signal	CPCONLY	C07K2319/08		47
C07K2319/09	9	containing a nuclear localisation signal	CPCONLY	C07K2319/09		1135
C07K2319/095	9	containing a nuclear export signal	CPCONLY	C07K2319/095		91
C07K2319/10	9	containing a tag for extracellular membrane crossing, e.g. TAT or VP22	CPCONLY	C07K2319/10		1706
C07K2319/20	8	containing a tag with affinity for a non-protein ligand	CPCONLY	C07K2319/20		1041
C07K2319/21	9	containing a His-tag	CPCONLY	C07K2319/21		3196
C07K2319/22	9	containing a Strep-tag	CPCONLY	C07K2319/22		329
C07K2319/23	9	containing a GST-tag	CPCONLY	C07K2319/23		624
C07K2319/24	9	containing a MBP (maltose binding protein)-tag	CPCONLY	C07K2319/24		416
C07K2319/30	8	Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto	CPCONLY	C07K2319/30		6956
C07K2319/31	8	fusions, other than Fc, for prolonged plasma life, e.g. albumin	CPCONLY	C07K2319/31		1414
C07K2319/32	8	fusions with soluble part of a cell surface receptor, "decoy receptors"	CPCONLY	C07K2319/32		807
C07K2319/33	8	fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies	CPCONLY	C07K2319/33		4812
C07K2319/35	8	containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin	CPCONLY	C07K2319/35		767
C07K2319/40	8	containing a tag for immunodetection, or an epitope for immunisation	CPCONLY	C07K2319/40		1630
C07K2319/41	9	containing a Myc-tag	CPCONLY	C07K2319/41		436
C07K2319/42	9	containing a HA(hemagglutinin)-tag	CPCONLY	C07K2319/42		395
C07K2319/43	9	containing a FLAG-tag	CPCONLY	C07K2319/43		786
C07K2319/50	8	containing protease site	CPCONLY	C07K2319/50		2646
C07K2319/55	8	containing a fusion with a toxin, e.g. diphteria toxin	CPCONLY	C07K2319/55		1015
C07K2319/60	8	containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]	CPCONLY	C07K2319/60		2068
C07K2319/61	8	containing an enzyme fusion for detection (lacZ, luciferase)	CPCONLY	C07K2319/61		749
C07K2319/70	8	containing domain for protein-protein interaction	CPCONLY	C07K2319/70		1463
C07K2319/705	9	containing a protein-A fusion	CPCONLY	C07K2319/705		155
C07K2319/71	9	containing domain for transcriptional activaation, e.g. VP16	CPCONLY	C07K2319/71		333
C07K2319/715	10	containing a domain for ligand dependent transcriptional activation, e.g. containing a steroid receptor domain	CPCONLY	C07K2319/715		96
C07K2319/72	9	containing SH2 domain	CPCONLY	C07K2319/72		36
C07K2319/73	9	containing coiled-coiled motif (leucine zippers)	CPCONLY	C07K2319/73		337
C07K2319/735	9	containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)	CPCONLY	C07K2319/735		750
C07K2319/74	9	containing a fusion for binding to a cell surface receptor	CPCONLY	C07K2319/74		1397
C07K2319/75	10	containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones	CPCONLY	C07K2319/75		984
C07K2319/80	8	containing a DNA binding domain, e.g. Lacl or Tet-repressor	CPCONLY	C07K2319/80		989
C07K2319/81	9	containing a Zn-finger domain for DNA binding	CPCONLY	C07K2319/81		483
C07K2319/85	8	containing an RNA binding domain	CPCONLY	C07K2319/85		274
C07K2319/90	8	containing a motif for post-translational modification	CPCONLY	C07K2319/90		153
C07K2319/91	9	containing a motif for glycosylation	CPCONLY	C07K2319/91		118
C07K2319/912	10	containing a GPI (phosphatidyl-inositol glycane) anchor	CPCONLY	C07K2319/912		36
C07K2319/915	9	containing a motif for acylation	CPCONLY	C07K2319/915		18
C07K2319/92	9	containing an intein ("protein splicing")domain	CPCONLY	C07K2319/92		253
C07K2319/95	8	containing a motif/fusion for degradation (ubiquitin fusions, PEST sequence)	CPCONLY	C07K2319/95		511
